New: Introducing the Finviz Crypto Map

Learn More

Performant Healthcare (PHLT) Surges 115.2%: Is This an Indication of Further Gains?

By Zacks Equity Research | August 04, 2025, 9:22 AM

Performant Healthcare PHLT shares soared 115.2% in the last trading session to close at $7.64. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% loss over the past four weeks.

Performant Healthcare recorded a strong price rise on investors’ optimism surrounding it’s preliminary second quarter 2025 financial results announced on August 1. The company expects second quarter revenues of approximately $37.8 million, net income of approximately $2.1 million, and adjusted EBITDA of approximately $6.2 million. Additionally, Performant Healthcare has entered into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital.  

This provider of audit and recovery services is expected to post quarterly loss of $0.03 per share in its upcoming report, which represents a year-over-year change of +25%. Revenues are expected to be $31 million, up 5.6% from the year-ago quarter.

Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.

For Performant Healthcare, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on PHLT going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Performant Healthcare belongs to the Zacks Medical Services industry. Another stock from the same industry, Enhabit EHAB, closed the last trading session 3% lower at $6.52. Over the past month, EHAB has returned -12.2%.

Enhabit's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.1. Compared to the company's year-ago EPS, this represents a change of +42.9%. Enhabit currently boasts a Zacks Rank of #3 (Hold).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Performant Healthcare, Inc. (PHLT): Free Stock Analysis Report
 
Enhabit, Inc. (EHAB): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News